Flipkart Achieves Record SingleDay Sales of 200 Million Marking Ecommerce Milestone UK Intelligence Chief Warns West Faces Moment of Consequence from RussiaChina Threats Singapore Maintains 2026 GDP Target of 24 Amid Elevated Geopolitical Risks From Iran Conflict Veteran Trader Steve Burns Warns of Potential 50 Decline Amid Ignored Bear Market Signal Best CD Rates on May 24 2026 Savers Can Lock in up to 4 APY China Confirms Order for 200 Boeing Jets Signaling Potential Thaw in USChina Trade Relations NEN Q4 2024 Earnings Real Estate Partnership Reports EPS of 3612 on Flat Trading Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues PLG Q4 2023 Earnings NarrowerThanExpected Loss Provides a Glimmer of Progress BrightView Holdings Inc Q1 2026 Earnings EPS Falls Short Amid Challenging Season OBDC Q1 2026 Earnings EPS Misses Estimates by 126 Shares Dip nVent Electric Q1 2026 Earnings Solid EPS Beat Despite Tepid Market Reaction GIII Apparel Group GIII Advances 192 as Shares Test Resistance Near 3456 Exponent Inc EXPO Bucks Market Trend With 233 Gain Tests Key Resistance High Roller Technologies ROLR Gains 269 as Stock Bounces from Support ESAB Corporation ESAB Holds Steady as Shares Edge Higher Testing Key Resistance Brookfield Asset Management BAM Gains 142 Testing Key Resistance Levels Toronto Blue Jays Legend Passes at Age Age Unknown from Source Senmiao Technology Limited AIHS Q1 2026 Earnings Narrowed Loss Amid Operational Challenges Rekor Systems REKR Holds at 077 as Minor Decline Tests Support Levels BK Q1 2026 Earnings Strong EPS Beat Highlights Operational Resilience Taiwan Arms Sales Emerge as Key Topic in TrumpXi Discussions The Cuba Pressure Campaign Intensifies Analysts See PreConflict Playbook Dynamics Glenmark Pharma and Manappuram Finance Among ShortTerm Opportunities Identified by Religare Broking Understanding Subjectto Mortgages A Creative Financing Strategy in Real Estate Could a New Central Banking Model Weaken Bond Market Influence on UK Politics Ocugen Q1 2026 Earnings EPS Misses Estimates Amid Continued PreClinical Stage